Skip to main content
Clinical Trials/NCT03804164
NCT03804164WithdrawnNot Applicable

A Study of the Feasibility and Acceptability of a Psycho-Educational Cognition Intervention in Adolescents and Young Adults (AYAs) With Cancer

City of Hope Medical Center1 site in 1 countryStarted: February 10, 2020Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Withdrawn
Sponsor
Locations
1
Primary Endpoint
Enrollment of eligible participants (accrual)

Study Overview

Brief Summary

This pilot trial studies how well a psycho-educational program called Emerging from the Haze works in helping patients with blood and lymph cancer. Sometimes, patients who have undergone treatment for cancer experience thinking or memory problems that make work, school, or everyday life activities, such as grocery shopping, difficult. The Emerging from the Haze program may provide resources to help deal with these types of challenges in patients with blood and lymph cancer.

Detailed Description

PRIMARY OBJECTIVES:

I. Demonstrate feasibility and acceptability for young adult survivors of various cancers utilizing Emerging from the Haze program.

SECONDARY OBJECTIVES:

I. Describe, summarize study population. II. Characterize, compare the measure scores at pre-intervention assessment to the measure scores at post-intervention assessment.

OUTLINE:

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Supportive Care
Masking
None

Eligibility Criteria

Ages
18 Years to 39 Years (Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •A diagnosis of a hematological malignancy.
  • •Having received chemotherapy with or without radiation therapy.
  • •Physician approval.
  • •Functional Assessment of Cancer Therapy-Cognition (FACT-COG) score < 59 on the perceived cognitive impairments (PCI) subscale.
  • •Eligible after 2 months (60 +/- 5 days) of completing all their active cancer treatment with the exception of patients that are post-transplant.
  • •Subjective complaint of cognitive concerns at time of enrollment.
  • •Must be able to understand and communicate proficiently in English.
  • •Ability to understand and the willingness to sign a written informed consent.
  • •Agree to complete study surveys.

Exclusion Criteria

  • •Patients who have significant personality disorders or unstable psychiatric disorders as assessed by the interviewing clinician.
  • •Patients with known brain metastases, history of brain metastases or radiation to the brain.
  • •Patients with a history of stroke or other pre-existing neurological condition that may contribute to cognitive dysfunction.
  • •Non-English speaking patients.

Arms & Interventions

Supportive Care (psycho-educational sessions)

Experimental

Patients participate in a psycho-educational program weekly over 2 hours for 6 weeks.

Intervention: Educational Intervention (Other)

Supportive Care (psycho-educational sessions)

Experimental

Patients participate in a psycho-educational program weekly over 2 hours for 6 weeks.

Intervention: Quality-of-Life Assessment (Other)

Supportive Care (psycho-educational sessions)

Experimental

Patients participate in a psycho-educational program weekly over 2 hours for 6 weeks.

Intervention: Survey Administration (Other)

Outcomes

Primary Outcomes

Enrollment of eligible participants (accrual)

Time Frame: Up to 30 days post the end of the six-week program

Feasibility will be assessed through enrollment of \>= 60% of eligible participants (accrual) and completion of at least 5 out of 6 sessions for \>= 80% of participants (adherence/engagement).

Completion of sessions (adherence/engagement)

Time Frame: Up to 30 days post the end of the six-week program

Feasibility will be assessed through enrollment of \>= 60% of eligible participants (accrual) and completion of at least 5 out of 6 sessions for \>= 80% of participants (adherence/engagement).

Secondary Outcomes

  • Change in Functional Assessment of Cancer Therapy-Cognition scores(Baseline up to 30 days post the end of the six-week program)
  • Change in Patient Reported Outcomes Measurement Information System (PROMIS) scores(Baseline up to 30 days post the end of the six-week program)
  • Change in Global Self-Report of Cognition scores(Baseline up to 30 days post the end of the six-week program)
  • Satisfaction Survey scores(Up to 30 days post the end of the six-week program)
  • Change in PROMIS-29 items (29) scores(Baseline up to 30 days post the end of the six-week program)

Investigators

Sponsor
City of Hope Medical Center
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials